Alzheimer’s Drug Discovery Foundation (ADDF) - 5th and 6th October 2020

The study of Alzheimer’s Disease is one of a wide range of Transpharmation’s preclinical specialisms. We are looking forward to having a recorded presentation of a recent study showing at the 21st International Conference on Alzheimer's Drug Discovery; ‘Peripheral Blood Mononuclear Cells (PBMCs): Implications for screening novel anti-inflammatories in Alzheimer’s Disease (AD).’ Please see here for further detail: publications / preclinical services. Please feel free to contact us about how we might be able to help you with your Alzheimer’s Disease studies.